Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Leukemia

Clinical Trial at: Texas Oncology - Dallas

A phase 3b study in previously untreated Chronic Lymphocytic Leukemia (CLL) subjects, excluding those with the 17p deletion, to evaluate debulking regimens prior to initiating venetoclax combination therapy (M16-788)

  • Details

ClinicalTrials.gov ID: NCT03406156
Diagnosis Type: CLL
USOR Number: 17106

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - Dallas

A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)

  • Details

ClinicalTrials.gov ID: NCT03941964
Diagnosis Type: NA
USOR Number: 18168

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Dallas

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Dallas

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Dallas

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab versus Placebo in Combination with Rituximab in Treatment Naïve Subjects with Follicular Lymphoma - PCYC-1141-CA

  • Details

ClinicalTrials.gov ID: NCT02947347
Diagnosis Type: Non-Hodgkins
USOR Number: 16176

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Dallas

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Dallas

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Dallas

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - Dallas

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Dallas

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Dallas

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Dallas

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Texas Oncology - Dallas

ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419)- Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer (GTI-4419-301)

  • Details

ClinicalTrials.gov ID: NCT03689712
Diagnosis Type: NA
USOR Number: 18182

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Texas Oncology - Dallas

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Texas Oncology - Dallas

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Texas Oncology - Dallas

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Dallas

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Texas Oncology - Dallas

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Texas Oncology - Dallas

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Uterine Cancer

Clinical Trial at: Texas Oncology - Dallas

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
296.45 mi. away
P: (214) 739-4175

More Details View Practice Page

Pages